CUVL Short Volume
Clinuvel Pharmaceuticals Ltd. (CUVL) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $310.6M, listed on NASDAQ, carrying a beta of 0.57 to the broader market. Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Led by Philippe Jacques Wolgen, public since 2026-07-13.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 13.2K
- Total Volume
- 16.2K
- Short %
- 81.29%
- 30-Day Avg Short %
- 53.15%
Showing 30 days of FINRA short volume data for Clinuvel Pharmaceuticals Ltd..
Learn how short volume is reported and how to read the data →
Frequently asked CUVL short volume questions
- What is the daily CUVL short volume?
- As of Aug 28, 2026, Clinuvel Pharmaceuticals Ltd. (CUVL) short volume is 13.2K shares against 16.2K total reported volume, or 81.29% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CUVL short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CUVL short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.